Grant Details

Grant Overview

General Information

Funding Organization: National Institutes of Health (NIH)

Total Funding Amount: Not specified

Duration: Up to five years

Primary Objective: Accelerate innovative drug and device discovery for mental health treatment

Mission Statement: Transform the understanding and treatment of mental illnesses through research

Key Stakeholders: Academic institutions, industry partners, NIH, and research communities

Eligibility Criteria

Organization Requirements

Eligible organization types include higher education institutions, nonprofits, for-profit organizations, local and state governments, and federal agencies.

Specific qualifications include having the necessary skills, knowledge, and resources to carry out the proposed research.

Non-domestic (non-U.S.) entities are not eligible to apply.

Geographic Scope

Organizations must be based in the U.S. or its territories.

Non-domestic components of U.S. organizations are not eligible.

Project Requirements

Projects must focus on drug/device discovery and development for mental disorders.

Partnerships between academia and industry are strongly encouraged.

Applications can include multiple scientific projects and cores.

Financial Requirements

Cost-sharing is not required.

Application budgets are not limited but must reflect actual project needs.

Timeline Requirements

Applications are due by 5:00 PM local time on specified due dates.

The total project period may not exceed five years.

Previous Funding Considerations

Organizations may submit more than one application, provided each is scientifically distinct.

Duplicate or overlapping applications will not be accepted.

Application Process

Required Documentation

Applications must follow the Multi-Project Instructions in the How to Apply - Application Guide.

A letter of intent is encouraged but not required.

Evaluation Criteria

Applications will be evaluated based on scientific merit, innovation, approach, and the qualifications of the investigators.

Review Process

Applications will undergo peer review and may receive a second level of review by the appropriate national Advisory Council or Board.

Special Considerations

Unique Aspects

The grant supports a cooperative agreement mechanism, indicating substantial NIH involvement.

Potential Challenges

Applicants must address potential challenges in their proposals and provide solutions.

Key Insights and Recommendations

Critical Success Factors

Strong collaboration between academic and industry partners is essential.

Clear milestones and timelines must be established.

Common Pitfalls to Avoid

Avoid submitting overlapping applications.

Ensure compliance with all application instructions.

Grant Details

mental health drug discovery device development clinical trials biotechnology pharmaceuticals research collaboration public-private partnerships
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)
PAR-25-353
NIH Mental Health Research Grants
EDU NGO ENTERPRISE PUBLIC OTHER
US
RESEARCH_DEVELOPMENT
False
None
None
None
USD
None
True
True
The grant aims to significantly advance the discovery and development of new therapeutics for mental disorders, enhancing the understanding of mental health treatment.
Successful applications will result in innovative drug and device candidates for mental health treatment.
Oct. 25, 2027, 9 p.m.
March 2028
Multi-Project Instructions, Letter of Intent (optional)
True
Peer review based on scientific merit and relevance to program priorities.
Applications must demonstrate innovative approaches to drug/device discovery.
Proposals should outline feasible project timelines and milestones.
Projects must address significant unmet needs in mental health treatment.
True
True
Cooperative Agreement
Recipients must comply with NIH policies and share data generated under the grant.
Annual progress reports and financial statements are required.
Payments will be made according to NIH guidelines.
All NIH grants are subject to federal regulations and NIH Grants Policy Statement.
No additional sector-specific requirements are specified.